# Filing Detail

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001062993-14-003434
Filing Date
2014-05-30
Accepted
2014-05-29 17:39:17
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q/A | form10qa.htm | 10-Q/A | 560278
2 | EXHIBIT 31.1 | exhibit31-1.htm | EX-31.1 | 4333
3 | EXHIBIT 32.1 | exhibit32-1.htm | EX-32.1 | 3279
| Complete submission text file | 0001062993-14-003434.txt |  | 7780796

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | avxl-20140331.xml | EX-101.INS | 617094
5 | XBRL SCHEMA FILE | avxl-20140331.xsd | EX-101.SCH | 248345
6 | XBRL CALCULATION FILE | avxl-20140331_cal.xml | EX-101.CAL | 39608
7 | XBRL DEFINITION FILE | avxl-20140331_def.xml | EX-101.DEF | 622261
8 | XBRL LABEL FILE | avxl-20140331_lab.xml | EX-101.LAB | 1630433
9 | XBRL PRESENTATION FILE | avxl-20140331_pre.xml | EX-101.PRE | 685533

Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 000-51652 | Film No.: 14877223
SIC: 8731 Services-Commercial Physical & Biological Research